.
abl
aggreg
also
analys
appl
approach
avail
bas
benefit
best
biocompat
cant
cas
cel
chemotherapy
comparison
conv
cre
dead
decid
delivery
demonst
distinct
drug
eff
effect
environ
ex
feat
fin
first
form
furtherm
fuzzy
geomet
group
healthy
high
ident
improv
includ
increas
limit
lingu
lung
mainstay
mak
many
med
method
moreov
mort
nanopartic
nanoparticle-based
norm
numb
off
oft
on
op
opt
optim
org
orthopair
pap
perm
pow
precid
pres
prev
propos
q-rung
rady
rat
rec
remain
resist
ret
select
sensit
sev
spar
spec
stabl
study
supery
system
target
therapy
theref
tox
tradit
tre
tum
us
valid
weight
worldwid
yag